NCT07646171
- Conditions
- Hormone Receptor Positive Breast Cancer
- Locations
-
- Ichilov-Sourasky Medical Center Tel Aviv, Israel
Clinical trial condition
Hormone Receptor Positive Breast Cancer
Explore clinical trials studying Hormone Receptor Positive Breast Cancer. Study availability and eligibility vary by location and protocol.
10 public trials
3 recruiting studies
Hormone Receptor Positive Breast Cancer trial results
Recruiting
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
NCT07222215
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
- Locations
-
- Centro di Riferimento Oncologico IRCCS Aviano, Italy
- Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
- Humanitas Istituto Clinico Catanese Catania, Italy
- ASST Lariana - Ospedale Sant'Anna Como, Italy
NCT01602380
- Conditions
- Hormone Receptor Positive Breast Cancer, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Research Site Modesto, California, United States
- Research Site Savannah, Georgia, United States
- Research Site Auburn, Maine, United States
- Research Site Worcester, Massachusetts, United States
NCT03854903
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Breast Cancer, +10 more
- Locations
-
- Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
NCT02675231
- Conditions
- HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer
- Locations
-
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- St Jude Medical Center Fullerton, California, United States
- TRIO - Translational Research in Oncology-US, Inc. Los Angeles, California, United States
- USC Norris Cancer Hospital Los Angeles, California, United States
NCT03227328
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Negative Breast Cancer, +6 more
- Locations
-
- U.O. Oncologia Medica, P.O. Bellaria-Maggiore Bologna, BO, Italy
- UO Oncologia Medica IRST IRCCS Meldola, FC, Italy
- Dip. Medicina Interna e Riabilitazione - U.O. Medicina Interna Oncologica, Ospedale Ramazzini Carpi, MO, Italy
- Dip. Oncologia-Ematologia - U.O. Oncologia Medica,Azienda USL di Piacenza - Ospedale Civile Piacenza, PC, Italy
NCT01698918
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Breast Cancer, +4 more
- Locations
-
- University of Alabama Comprehensive Cancer Center SC-2 Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Loma Linda University Loma Linda Loma Linda, California, United States
- Breastlink Medical Group Dept. of BreastlinkResearchGrp Long Beach, California, United States
Active, Not Recruiting
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
NCT04569747
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Stamford Hospital Stamford, Connecticut, United States
- University of Miami- Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Winship Cancer Institute at Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University - Winship Cancer Institute Atlanta, Georgia, United States
Active, Not Recruiting
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
NCT03401385
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +15 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- Johns Hopkins University Baltimore, Maryland, United States